Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

NCT01869764 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ
Male Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

DRUG: omega-3 fatty acid
OTHER: placebo
OTHER: laboratory biomarker analysis

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]